Moreover, in a subsequent study, it was shown that an increased mortality among patients with ovarian carcinoma was rather due to a downregulation of HLA class I expression caused by HER-2/neu overexpression and/or haplotype loss [37], mechanisms not specifically related to the HLA-A2 phenotype. The gene discussed is ERBB2; the disease is ovarian carcinoma.